Journal
CANCER CELL
Volume 29, Issue 4, Pages 477-493Publisher
CELL PRESS
DOI: 10.1016/j.ccell.2016.02.010
Keywords
-
Categories
Funding
- Department of Energy
- National Institutes of Health
- National Institute of General Medical Sciences
- National Center for Research Resources
Ask authors/readers for more resources
Activating mutations in protein kinases drive many cancers. While how recurring point mutations affect kinase activity has been described, the effect of in-frame deletions is not well understood. We show that oncogenic deletions within the beta 3-alpha C loop of HER2 and BRAF are analogous to the recurrent EGFR exon 19 deletions. We identify pancreatic carcinomas with BRAF deletions mutually exclusive with KRAS mutations. Crystal structures of BRAF deletions reveal the truncated loop restrains alpha C in an active in'' conformation, imparting resistance to inhibitors like vemurafenib that bind the alpha C out'' conformation. Characterization of loop length explains the prevalence of five amino acid deletions in BRAF, EGFR, and HER2 and highlights the importance of this region for kinase activity and inhibitor efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available